SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001230
Filing Date
2023-05-15
Accepted
2023-05-15 16:30:51
Documents
54
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ckpt-20230331x10q.htm   iXBRL 10-Q 1227730
2 EX-31.1 ckpt-20230331xex31d1.htm EX-31.1 8633
3 EX-31.2 ckpt-20230331xex31d2.htm EX-31.2 8566
4 EX-32.1 ckpt-20230331xex32d1.htm EX-32.1 5244
5 EX-32.2 ckpt-20230331xex32d2.htm EX-32.2 5177
  Complete submission text file 0001410578-23-001230.txt   5236436

Data Files

Seq Description Document Type Size
6 EX-101.SCH ckpt-20230331.xsd EX-101.SCH 46493
7 EX-101.CAL ckpt-20230331_cal.xml EX-101.CAL 23015
8 EX-101.DEF ckpt-20230331_def.xml EX-101.DEF 218531
9 EX-101.LAB ckpt-20230331_lab.xml EX-101.LAB 376175
10 EX-101.PRE ckpt-20230331_pre.xml EX-101.PRE 298997
48 EXTRACTED XBRL INSTANCE DOCUMENT ckpt-20230331x10q_htm.xml XML 743246
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38128 | Film No.: 23923135
SIC: 2834 Pharmaceutical Preparations